Article ID Journal Published Year Pages File Type
1394982 European Journal of Medicinal Chemistry 2010 6 Pages PDF
Abstract
257We designed novel, highly potent neuraminidase inhibitors by substitution at the C3 position of oseltamivir to give additional interaction with the 150-cavity of subtype N1.
Related Topics
Physical Sciences and Engineering Chemistry Organic Chemistry
Authors
, ,